Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma

BACKGROUND: The present study aimed to investigate the impact of pre-sarcopenia on the prognosis of patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib. METHODS: We enrolled 214 patients (71 ± 10 years old; 166 men and 48 women; 90% Child–Pugh grade A and 10% Child–Pugh grad...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Takada, Hitomi, Kurosaki, Masayuki, Nakanishi, Hiroyuki, Takahashi, Yuka, Itakura, Jun, Tsuchiya, Kaoru, Yasui, Yutaka, Tamaki, Nobuharu, Takaura, Kenta, Komiyama, Yasuyuki, Higuchi, Mayu, Kubota, Youhei, Wang, Wann, Okada, Mao, Enomoto, Nobuyuki, Izumi, Namiki
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2018
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6005492/
https://ncbi.nlm.nih.gov/pubmed/29912922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0198812
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki